v3.26.1
Stockholders' Equity (Tables)
 6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity
Stock option activity during the six months ended June 30, 2026, was as follows (in thousands, except per share amounts):
Stock Options Outstanding
SharesWeighted-Average Exercise PriceWeighted-Average Remaining Contractual Term
Aggregate Intrinsic
Value (1)
(in years)
Outstanding as of December 31, 20258,554$19.96 6.5$50,720 
Outstanding as of June 30, 20268,554$19.96 6.0$9,152 
Exercisable as of June 30, 20268,019$19.96 6.0$8,580 
(1)We calculate intrinsic value based on the difference between the exercise price of in-the-money-stock options and the fair value of our common stock as of the respective balance sheet date.
Schedule of Restricted Stock Unit Activity
RSU and RSA activity during the six months ended June 30, 2026, was as follows (in thousands, except per share amounts):
Restricted Stock Units and Restricted Stock Awards Outstanding
SharesWeighted Average Grant Date Fair Value
Outstanding as of December 31, 202539,119$30.25 
Granted
59,19019.19 
Released(20,947)24.72 
Forfeited
(8,277)25.86 
Outstanding as of June 30, 202669,085$22.97 
Schedule of Share-Based Compensation Expense
Share-based compensation expense during the three and six months ended June 30, 2026 and 2025, was as follows (in thousands):
Three Months Ended
June 30,		Six Months Ended
June 30,
2026202520262025
Cost of revenue
$8,484 $4,983 $13,046 $9,055 
Research and development212,537 145,939 353,213 265,421 
Sales and marketing52,155 38,715 91,099 69,046 
General and administrative
46,553 37,597 84,492 71,138 
Restructuring
4,788 — 14,113 — 
Total share-based compensation
$324,517 $227,234 $555,963 $414,660